Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B
Year: 2005
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon, Gloria A. Niehans, Robin Vollmer, Dorothy Watson, Mark R. Green, Hedy L. Kindler, on behalf of the Cancer and Leukemia Group B (CALGB 30101)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: Cancer and Leukemia Group B
OpenAlex ID: W2113954569
